Baxter International Inc/ US0718131099 /
2024-08-08 5:53:22 PM | Chg. +0.38 | Volume | Bid2024-08-08 | Ask2024-08-08 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
36.97USD | +1.04% | 725,301 Turnover: 20.86 mill. |
36.97Bid Size: 300 | 36.99Ask Size: 500 | 18.73 bill.USD | 3.15% | 7.02 |
GlobeNewswire
06-26
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
GlobeNewswire
06-20
ProvisionAi COO Terri Bennett Robbins Named One of 20 Women Reshaping the Future of Logistics and th...
GlobeNewswire
06-20
E-fuels offer long-term solution to key energy transition transport sectors, but journey needs to st...
GlobeNewswire
06-14
CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payme...
GlobeNewswire
06-12
2024 RealTrends + Tom Ferry The Thousand List Recognizes 44 eXp Realty Agents and Teams
GlobeNewswire
06-12
2024 Report: LGBTQ+ Advertising Influential Over Brand Perceptions & Purchase Decisions
GlobeNewswire
06-04
Wood Mackenzie appoints Xizhou Zhou as new head of Power and Renewables Business
GlobeNewswire
05-16
US November election results could decelerate energy transition, with $1 trillion in energy investme...
GlobeNewswire
05-15
Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityB...